Convalescent plasma may be considered in COVID-19 patients with moderate disease who are not improving (oxygen requirement is progressively increasing) despite use of steroids, noted a one-page advisory issued by the Central Drugs Standard Control Organisation (Biological Division), here on Wednesday.
Also read: Study on plasma therapy is ongoing: ICMR
The Health Ministry last week released guidelines on clinical management protocol for COVID-19 where certain therapies were indicated for use as investigational therapies, in which convalescent plasma by plasmapheresis has been indicated as “Off Label” in COVID-19 patients’.
The organisation has specified special prerequisites while considering convalescent plasma — ABO compatibility ...
Read the full text thehindu